Adherence to Oral Anticoagulants in Atrial Fibrillation: An Australian Survey
MetadataShow full item record
© 2018, The Author(s) 2018. Background: The aim of this study was to investigate the proportion of patients who have suboptimal adherence to oral anticoagulant (OAC), identify the predictors of adherence, and determine whether patient-related factors vary across adherence levels in Australia. Methods: Respondents were recruited for an online survey using Facebook. Survey instruments included the Morisky Medication Adherence Scale, the Anticoagulation Knowledge Tool, the Perception of Anticoagulant Treatment Questionnaires, and a modified Cancer Information Overload scale. Predictors of medication adherence were identified using ordinal regression analysis. Results: Of the 386 responses eligible for analysis, only 54.9% reported a high level of adherence. Participants aged 65 years or younger were less likely to have high adherence compared to older participants (odds ratio [OR], 0.54; 95% confidence interval [CI] , 0.33-0.88; P =.013), while females were more likely to be highly adherent compared to males (OR, 1.69; 95% CI, 1.08-2.64; P =.023). The analyses showed that age, gender, treatment satisfaction, information overload, concerns about making mistake when taking OACs, and cost of medication were significant predictors of adherence. Conclusion: Self-reported suboptimal adherence to OAC is common among patients with atrial fibrillation. A focus on supporting people who are at higher risk of suboptimal adherence is needed to maximize the benefit of OAC therapy in this population.
Showing items related by title, author, creator and subject.
Obamiro, K.; Chalmers, Leanne; Lee, K.; Bereznicki, B.; Bereznicki, L. (2018)© 2018 John Wiley & Sons Ltd Background: Atrial fibrillation (AF) is the most commonly diagnosed arrhythmia in clinical practice, and is associated with a significant medical and economic burden. Anticoagulants reduce ...
Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International clarify registryFauchier, L.; Greenlaw, N.; Ferrari, R.; Ford, I.; Fox, K.; Tardif, J.; Tendera, M.; Steg, P.; Sokn, F.; Reid, Christopher; Lang, I.; Van Den Branden, F.; César, L.; Mattos, M.; Luqman, H.; Goudev, A.; Dorian, P.; Hu, D.; Widimsky, P.; Hassager, C.; Danchin, N.; Kääb, S.; Vardas, P.; Sulaiman, K.; Al Mahmeed, W.; Al Suwaidi, J.; Al Rashdan, I.; Abdulkader, F.; Merkely, B.; Kaul, U.; Daly, K.; Tavazzi, L.; Jang, Y.; Erglis, A.; Laucevicius, A.; Jamaluddin, A.; Gamba, M.; Tulevski, I.; Stepinska, J.; Morais, J.; Macarie, C.; Oganov, R.; Shalnova, S.; Al-Zaibag, M.; Hou, M.; Kamensky, G.; Fras, Z.; Kanic, V.; Naidoo, D.; Zamorano, J.; Rickli, H.; Jaussi, A.; Sriratanasathavorn, C.; Kalra, P.; Lutai, M.; Oleksandr; Nguyen, L.; Henry, R. (2015)© 2015 Fauchier et al. Background: Few data are available regarding the use of antithrombotic strategies in coronary artery disease patients with atrial fibrillation (AF) in everyday practice. We sought to describe the ...
Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial FibrillationAdmassie, E.; Stafford, Leanne; Bereznicki, L. (2017)© 2017 Elsevier Inc. Suboptimal guideline adherence and underuse of anticoagulants in patients with atrial fibrillation (AF) have been reported worldwide. This study aimed to compare anticoagulation practice in Australia ...